Jana Radewonuk

515 total citations
7 papers, 285 citations indexed

About

Jana Radewonuk is a scholar working on Clinical Psychology, Sociology and Political Science and Psychiatry and Mental health. According to data from OpenAlex, Jana Radewonuk has authored 7 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Clinical Psychology, 1 paper in Sociology and Political Science and 1 paper in Psychiatry and Mental health. Recurrent topics in Jana Radewonuk's work include Eating Disorders and Behaviors (7 papers), Obsessive-Compulsive Spectrum Disorders (7 papers) and Body Image and Dysmorphia Studies (3 papers). Jana Radewonuk is often cited by papers focused on Eating Disorders and Behaviors (7 papers), Obsessive-Compulsive Spectrum Disorders (7 papers) and Body Image and Dysmorphia Studies (3 papers). Jana Radewonuk collaborates with scholars based in United States and Hungary. Jana Radewonuk's co-authors include Maria Gasior, James I. Hudson, Susan L. McElroy, M. Celeste Ferreira‐Cornwell, Timothy Whitaker, Javier Quintero, Barry K. Herman, Denise E. Wilfley, Joan Busner and David V. Sheehan and has published in prestigious journals such as Neuropsychopharmacology, JAMA Psychiatry and International Journal of Eating Disorders.

In The Last Decade

Jana Radewonuk

7 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jana Radewonuk United States 5 256 57 46 37 35 7 285
Barbara Mezzani Italy 7 303 1.2× 44 0.8× 81 1.8× 54 1.5× 16 0.5× 12 342
Kirsten Hørder Denmark 11 250 1.0× 65 1.1× 64 1.4× 22 0.6× 21 0.6× 19 335
William P. Carter United States 5 219 0.9× 63 1.1× 43 0.9× 21 0.6× 74 2.1× 6 309
Maria Giulia Martini United Kingdom 8 214 0.8× 94 1.6× 129 2.8× 19 0.5× 47 1.3× 10 322
Maria C. La Via United States 6 281 1.1× 130 2.3× 61 1.3× 28 0.8× 8 0.2× 10 322
Laura Dalla Ragione Italy 8 204 0.8× 52 0.9× 43 0.9× 42 1.1× 4 0.1× 18 246
Jill A. Gaskill United States 8 380 1.5× 142 2.5× 44 1.0× 81 2.2× 13 0.4× 8 399
B. S. Coleman United Kingdom 3 142 0.6× 55 1.0× 31 0.7× 12 0.3× 69 2.0× 5 223
G.N. Papadimitriou Greece 10 105 0.4× 96 1.7× 14 0.3× 23 0.6× 31 0.9× 30 284
Eloisa Castaldo Italy 9 244 1.0× 21 0.4× 64 1.4× 20 0.5× 23 0.7× 11 356

Countries citing papers authored by Jana Radewonuk

Since Specialization
Citations

This map shows the geographic impact of Jana Radewonuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Radewonuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Radewonuk more than expected).

Fields of papers citing papers by Jana Radewonuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Radewonuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Radewonuk. The network helps show where Jana Radewonuk may publish in the future.

Co-authorship network of co-authors of Jana Radewonuk

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Radewonuk. A scholar is included among the top collaborators of Jana Radewonuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Radewonuk. Jana Radewonuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Sheehan, David V., Maria Gasior, Susan L. McElroy, et al.. (2018). Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials.. PubMed. 15(5-6). 22–29. 7 indexed citations
2.
McElroy, Susan L., James I. Hudson, Maria Gasior, et al.. (2017). Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder. International Journal of Eating Disorders. 50(8). 884–892. 17 indexed citations
3.
Gasior, Maria, James I. Hudson, Javier Quintero, et al.. (2017). A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder. Journal of Clinical Psychopharmacology. 37(3). 315–322. 37 indexed citations
4.
Hudson, James I., Susan L. McElroy, M. Celeste Ferreira‐Cornwell, Jana Radewonuk, & Maria Gasior. (2017). Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder. JAMA Psychiatry. 74(9). 903–903. 90 indexed citations
5.
Pawaskar, Manjiri, Tamás Ágh, Jana Radewonuk, et al.. (2015). Longitudinal Modeling Of The Relationship Between Lisdexamfetamine Dimesylate And Health-Related Quality Of Life In Adults With Moderate To Severe Binge Eating Disorder. Value in Health. 18(7). A407–A407. 1 indexed citations
6.
McElroy, Susan L., James I. Hudson, M. Celeste Ferreira‐Cornwell, et al.. (2015). Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials. Neuropsychopharmacology. 41(5). 1251–1260. 132 indexed citations
7.
Pawaskar, Manjiri, Zoltán Vokó, Tamás Ágh, et al.. (2015). Longitudinal Modeling The Effect Of Lisdexamfetamine Dimesylate And Changes In Binge Eating Frequency On Disability In Patients With Binge Eating Disorder. Value in Health. 18(7). A407–A407. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Mezzani Breakdown of academic impact, for papers by Kirsten Hørder Breakdown of academic impact, for papers by William P. Carter Breakdown of academic impact, for papers by Maria Giulia Martini Breakdown of academic impact, for papers by Maria C. La Via Breakdown of academic impact, for papers by Laura Dalla Ragione Breakdown of academic impact, for papers by Jill A. Gaskill Breakdown of academic impact, for papers by B. S. Coleman Breakdown of academic impact, for papers by G.N. Papadimitriou Breakdown of academic impact, for papers by Eloisa Castaldo
Rankless by CCL
2026